Literature DB >> 10781950

Expression domains of murine ephrin-A5 in the pituitary and hypothalamus.

K Zarbalis1, W Wurst.   

Abstract

Using in situ hybridization on whole-mounts and sections of mouse embryos we have visualized the pattern of expression for the Eph receptor ligand ephrin-A5. Non neuronal expression domains include the ectoderm of the branchial arches, the ectoderm and mesenchyme surrounding the dorsal root ganglia, the intervertebral discs, maxillary and mandibulary mesenchymal elements as well as the nasal mesenchyme and ectoderm. Within the developing nervous system, ephrin-A5 expression is very dynamic. Besides the midbrain it is also expressed in the hypothalamus, and the neurohypophysis that we studied here in more detail. Hypothalamus expression of ephrin-A5 demarks distinct nuclei, persists throughout embryonic development, and can be seen also in the adult.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781950     DOI: 10.1016/s0925-4773(00)00252-5

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  13 in total

1.  Decreased maternal behavior and anxiety in ephrin-A5-/- mice.

Authors:  M Sheleg; Q Yu; C Go; G C Wagner; A W Kusnecov; R Zhou
Journal:  Genes Brain Behav       Date:  2016-09-22       Impact factor: 3.449

2.  Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development.

Authors:  Konstantinos Zarbalis; Julie A Siegenthaler; Youngshik Choe; Scott R May; Andrew S Peterson; Samuel J Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 3.  Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways.

Authors:  Leonard Y M Cheung; Shannon W Davis; Michelle L Brinkmeier; Sally A Camper; María Inés Pérez-Millán
Journal:  Mol Cell Endocrinol       Date:  2016-09-17       Impact factor: 4.102

4.  Retinoic acid from the meninges regulates cortical neuron generation.

Authors:  Julie A Siegenthaler; Amir M Ashique; Konstantinos Zarbalis; Katelin P Patterson; Jonathan H Hecht; Maureen A Kane; Alexandra E Folias; Youngshik Choe; Scott R May; Tsutomu Kume; Joseph L Napoli; Andrew S Peterson; Samuel J Pleasure
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

5.  Ephrin-A5 deficiency alters sensorimotor and monoaminergic development.

Authors:  Michal Sheleg; Carrie L Yochum; George C Wagner; Renping Zhou; Jason R Richardson
Journal:  Behav Brain Res       Date:  2012-08-27       Impact factor: 3.332

6.  Otx2 regulates subtype specification and neurogenesis in the midbrain.

Authors:  Bertrand Vernay; Muriel Koch; Flora Vaccarino; James Briscoe; Antonio Simeone; Ryoichiro Kageyama; Siew-Lan Ang
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

7.  EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia.

Authors:  Barbara Szepietowska; Wanling Zhu; Jan Czyzyk; Tore Eid; Robert S Sherwin
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

8.  Meningeal defects alter the tangential migration of cortical interneurons in Foxc1hith/hith mice.

Authors:  Konstantinos Zarbalis; Youngshik Choe; Julie A Siegenthaler; Lori A Orosco; Samuel J Pleasure
Journal:  Neural Dev       Date:  2012-01-17       Impact factor: 3.842

9.  Hypothalamic EphA5 facilitates counterregulatory responses: possible role for bidirectional signaling leading to bistability that enhances responsiveness to hypoglycemia.

Authors:  Charles V Mobbs; Cesar Moreno
Journal:  Diabetes       Date:  2013-04       Impact factor: 9.461

10.  A mutation in mouse Pak1ip1 causes orofacial clefting while human PAK1IP1 maps to 6p24 translocation breaking points associated with orofacial clefting.

Authors:  Adam P Ross; M Adela Mansilla; Youngshik Choe; Simon Helminski; Richard Sturm; Roy L Maute; Scott R May; Kamil K Hozyasz; Piotr Wójcicki; Adrianna Mostowska; Beth Davidson; Iannis E Adamopoulos; Samuel J Pleasure; Jeffrey C Murray; Konstantinos S Zarbalis
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.